CD8A and melanoma: Fourth, melanoma cell-derived exosomal PD-L1 inhibits cytokine production and cytotoxicity of CD8+ T cells by decreasing the expression of GzmB and inhibiting the production of interleukin-2 (IL-2) and tumor necrosis factor (TNF) (8).